New developments in sustained release drug delivery for the treatment of intraocular disease

Br J Ophthalmol. 1999 Nov;83(11):1225-9. doi: 10.1136/bjo.83.11.1225.

Authors

G Velez¹, S M Whitcup

Affiliation

¹ National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

No abstract available

Publication types

Review

MeSH terms

Antiviral Agents / therapeutic use
Blood-Aqueous Barrier
Cyclosporine / therapeutic use
Delayed-Action Preparations
Drug Implants
Eye Diseases / drug therapy
Ganciclovir / therapeutic use
Glucocorticoids / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Retinal Diseases / drug therapy*
Vitreous Body*

Substances

Antiviral Agents
Delayed-Action Preparations
Drug Implants
Glucocorticoids
Immunosuppressive Agents
Cyclosporine
Ganciclovir